All News

The drug is currently undergoing a phase 2 clinical trial for patient 12 years or older who are hospitalized with steroid-refractory acute graft-versus-host disease (aGVHD).

The combination is the first and only multi-targeted chemotherapy-free regimen that demonstrated superiority compared with osimertinib for non–small cell lung cancer (NSCLC).

Palliative pharmacists are invaluable assets of oncologic care.

The highly potent, selective URAT1 inhibitor may help reduce serum uric acid levels and treat clinically visible tophi.

In a session at NACDS Total Store Expo, experts spoke to the success of value-based care models in the pharmaceutical industry.

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

Fam-trastuzumab deruxtecan-nxki has received 4 breakthrough therapy designations, including the latest approval.

Currently, the drug will be studied in the SKYBRIDGE (NCT05652686) trial, a first-in-human, phase 1/2, open-label, dose-escalation and expansion study.

The biosimilar space continues to grow, with key focuses around retina and oncology, but adoption remains slow in the United States.

The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.

Noticing indicators of IVIG non-responsiveness can lead to better outcomes among patients with Kawasaki disease as treatment is adjusted.

Glucagon-like peptide-1 receptor agonists and sodium-glucose contransporter-2 inhibitors have been added as first-line therapy recommendation for type 2 diabetes, the first since metformin

Pharmacists should educate patients about proper medication storage and offer naloxone to optimize safety.

This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.

Craig Beavers discusses significance of the 2024 update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure.

CAR T-cell therapy in multiple myeloma faces challenges from the immunosuppressive cells in the tumor microenvironment.

Nurx reproductive access survey reveals 28% of women do not believe their right to contraception is protected.

The updates are based on nationwide reports of extreme pain during IUD insertion.

AI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.

Investigators analyzed a series of disease-modifying therapies in a multi-decade trial.

The hemostatic gel is plant-based and designed to stop and control bleeding within seconds after applied to wound at the point of care.

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.